Psilocybin
19 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Psilocybin for agnosia | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Psilocybin for alcoholism | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 8 |
| Psilocybin for anhedonia | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| Psilocybin for anxiety disorders | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 5 |
| Psilocybin for bipolar disorder | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Psilocybin for borderline personality disorder | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Psilocybin for cocaine-related disorders | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Psilocybin for depressive disorder, treatment-resistant | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 8 |
| Psilocybin for generalized anxiety disorder | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Psilocybin for major depressive disorder | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 19 |
| Psilocybin for migraine disorders | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| Psilocybin for neoplasms | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 5 |
| Psilocybin for neuralgia | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| Psilocybin for obsessive-compulsive disorder | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 4 |
| Psilocybin for paraplegia | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Psilocybin for parkinson disease | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| Psilocybin for quadriplegia | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Psilocybin for stress disorders, post-traumatic | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 3 |
| Psilocybin for wounds and injuries | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |